Análisis Argos
MOH
MOHSin veredicto1 señal de riesgo
Molina Healthcare, Inc. · Healthcare
US$ 229.87
precio al 2026-07-04
Valor justo Argos*
US$ 219
vs. su valor justo
−5%
Score Argos
50/100
Sin veredicto
LA RESPUESTA
No tenemos un veredicto de valuación confiable acá: su flujo de caja no permite una estimación sólida. Mirá su calidad y su salud para formarte una idea — preferimos eso a inventarte un número.
Recompensas
Retorno sobre el capital alto (17%).
Tiene más caja que deuda: balance fuerte.
Riesgos
!Cotiza 5% por encima de su valor justo.
!FCF negativo con deuda creciente
VALOR3/6FUTURO3/6PASADO3/6SALUD3/6DIVIDENDO5/6
El Iris de calidad
VALOR3/6FUTURO3/6PASADO3/6SALUD3/6DIVIDENDO5/6
ValorCerca de su valor justo
FuturoCrecimiento moderado
PasadoHistorial aceptable
SaludBalance razonable
DividendoDevuelve capital al accionista
Score Argos50de 100Sin veredicto
Ingresos12%
US$ 45.4 B
Margen operativo60%
1.7%
Flujo de caja libre219%
US$ -0.6 B
Deuda neta
US$ -0.3 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 12.0B
P/E25.4x
EV/EBITDA12x
FCF yield-5.3%
ROIC16.6%
Margen operativo1.7%
Crecim. ingresos+11.7%/año
Piotroski F4/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

zacks.com · 1 jul
Is Molina Healthcare (MOH) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
fool.com · 30 jun
State Street SPDR Small Cap ETF Outpaces iShares on Returns
Explore how portfolio size and sector exposure differ between these two small-cap ETFs, each offering unique advantages for investors.
zacks.com · 29 jun
Molina (MOH) Soars 6.3%: Is Further Upside Left in the Stock?
Molina (MOH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
247wallst.com · 26 jun
The Greenblatt Magic Formula: How H&R Block, Molina, and Peabody Stack Up for Retirement Investors
Joel Greenblatt's Magic Formula ranks stocks on two factors: earnings yield (EBIT divided by enterprise value) and return on capital.
247wallst.com · 18 jun
Michael Burry Called the 2008 Crash. Now He's Shorting Nvidia to Buy This Boring Healthcare Stock.
Before Michael Burry shut down Scion Asset Management in late 2025 and pivoted to publishing a Substack newsletter warning of an “AI Bubble,” his final 13F filings reportedly disclosed put options against NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) and Palantir (NASDAQ:PLTR) alongside a heavy rotation, around 51% of the disclosed portfolio, into health insurer Molina Healthcare.
businesswire.com · 17 jun
Molina Healthcare of Michigan and The MolinaCares Accord Donate $275,000 to Genesee County Habitat for Humanity
FLINT, Mich.--(BUSINESS WIRE)--Molina Healthcare of Michigan and The MolinaCares Accord donate $275,000 to Genesee County Habitat for Humanity.
zacks.com · 15 jun
Is Molina Healthcare (MOH) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
businesswire.com · 10 jun
Molina Healthcare Wins Illinois Medicaid Contract
LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) (“Molina”) announced today that the Illinois Department of Healthcare and Family Services (HFS) intends to award a HealthChoice Illinois Medicaid Managed Care program contract to Molina's Illinois health plan subsidiary, Molina Healthcare of Illinois. The go-live date for the new contract is expected to be January 1, 2027. The contract is expected to have a duration of four-and-a-half years, with the option to extend the c.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.